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Abstract  
                 
Although chronic postsurgical pain (CPSP) is a major health care problem, pain-related 
functional interference has rarely been investigated. Using the PAIN OUT registry we 
evaluated patients’ pain-related outcomes on the first postoperative day, and their pain-related 
interference with daily living (Brief Pain Inventory) and neuropathic symptoms (DN4: douleur 
neuropathique en 4 questions) at six months after surgery. Endpoints were pain interference 
total scores (PITS) and their association with pain and DN4 scores. Furthermore, possible risk 
factors associated with impaired function at M6 were analyzed by ordinal regression analysis 
with PITS groups (no to mild, moderate and severe int rference) as a dependent three-stage 
factor. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. Of 2,322 patients, 
15.3% reported CPSP with an average pain score ≥3 (NRS 0-10). Risk for a higher PITS group 
increased by 190% (OR (95%-CI): 2.9 (2.7-3.2); p<0.001) in patients with, compared to 
without CPSP. A positive DN4 independently increased risk by 29% (1.3 (1.12-1.45), p<0.001). 
Pre-existing chronic pain (3.6 (2.6-5.1); p<0.001), time spent in severe acute pain (2.9 (1.3-6.4); 
p=0.008), neurosurgical back surgery in males (3.6 1 7-7.6); p<0.001) and orthopedic surgery 
in females (1.7 (1.0-3.0); p=0.036) were the variables with strongest association with PITS. 
PITS might provide more precise information about patients’ outcomes than pain scores only. 
As neuropathic symptoms increase PITS, a suitable instrument for their routine assessment 
should be defined.  
 
Keywords: Chronic postsurgical pain (CPSP), Neuropathic pain, Brief Pain Inventory (BPI), 
Pain Interference Total Score (PITS), Pain scores 
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INTRODUCTION 
 
Prophylaxis and treatment of chronic postsurgical pain (CPSP) is recognized as a health priority 
[31], and the diagnosis “CPSP” is now included in the upcoming ICD-11, the international clas-
sification of diseases. CPSP has been considered an iatrogenically induced chronic pain,  mak-
ing identification of mechanisms and risk factors pivotal in order to prevent it [13]. Severe 
CPSP can result in clinically relevant functional interference, and is reported by 5-10% of pa-
tients after surgery [9,13]. However, many studies focused only on pain intensity, without con-
sidering the functional consequences of severe CPSP. In particular, neuropathic pain seems to 
be a major problem, with patients reporting an increase in pain intensity as well as pain-related 
interference [2,13,17,29]. Thus, to capture the full picture of disability caused by CPSP, an as-
sessment of patients’ functional interference has been recommended [13,18]. 
In order to describe the characteristics of patients suffering from (neuropathic) CPSP and their 
functional interference as well as possible risk factors in more detail, we analyzed data from the 
international pain registry PAIN OUT [39]. The registry provides details of pain-related func-
tional interference and neuropathic symptoms, based on results of the International Pain Out-
comes Questionnaire administered on the first postoerative day, as well as results of the Brief 
Pain Inventory (BPI) and the DN4 questionnaires filled in 6 months after surgery [6,9,24]. 
The aim of the study was to investigate functional i terference six months after surgery in a 
large cohort of patients undergoing medium sized to major surgery. The hypothesis was that 
pain intensities or the presence of CPSP are associated with pain interference total scores 
(PITS), and that neuropathic symptoms (positive DN4) contribute to functional interference. 
Furthermore, we wanted to identify potential risk factors for pain-related functional interference 
six month after surgery.  
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METHODS 
 
PAIN OUT registry 
Basis of this analysis is the PAIN OUT registry, which provides tools for benchmarking and 
quality control of postoperative pain outcomes (ClinicalTrials.gov: NCT02083835) [24,39]. 
Each participating center obtained ethics approval from its local ethics committee (for Bern 
University Hospital: KEK 074/11). Patients schedule for elective surgery gave informed 
consent for this prospective observational study according to the local requirements [28].  
Data collected within this registry reflect clinical practice in perioperative (analgesic) care. Pa-
tient histories and anesthesia- and surgery-related data were collected from the records. On the 
first postoperative day, patients filled in the International Pain Outcome Questionnaire asking for 
pain intensity scores, pain-related functional interference, and side effects of treatment using a 
numeric rating scale NRS 0-10 [24]. Some items were addressed with yes/no answers (e.g., de-
sire for more treatment) or a percentage scale (time spent in severe pain during the first 24 hours 
after surgery, pain relief).  
To prevent bias, trained surveyors not involved in patients’ care collected data in the participat-
ing hospitals and entered them in the web-based case report form. Composite pain scores were 
calculated for pain intensities reported on the first postoperative day, functional interference 
(mean NRS for “how pain interfered with activities in bed and out of bed, NRS for breathing 
deeply or coughing and sleeping”) and side effects (mean NRS for dizziness, drowsiness, itch-
ing and nausea).  
 
Patient assessment six months after surgery 
Six months after surgery, patients filled in the short form of the Brief Pain Inventory (BPI), 
which asked for pain intensity, pain relief experienc d from analgesic treatment, and pain-
related common dimensions of physical and affective int rference within the previous 24 hours 
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[6]. Questions addressed only pain related to the previous surgery. Patients were advised not to 
report pain or discomfort unrelated to their surgery, such as low back pain, arthritis pain, or 
headache. The BPI pain score summarizes NRS scores for average, least, worst and current pain 
(“pain right now”). Pain-related functional interfeence was calculated as a pain interference to-
tal score (PITS) from the seven respective question of the BPI [26], capturing the reactive di-
mension of pain, as recommended by the BPI user guide. Additionally, mean scores for the two 
domains physical interference (general activity, walking ability, work) and affective interfer-
ence (mood, enjoyment of life, relations with other persons) were calculated. Sleep was handled 
as a separate third factor, as it does not improve psychometric properties of the BPI interference 
scale [33-35]. According to their PITS scores, patients were allocated the groups: no interfer-
ence (PITS=0), mild interference (PITS >0 and <2), moderate interference (PITS 2-5) and se-
vere interference (PITS >5), as previously published [26]. 
Neuropathic symptoms were assessed using the interview version of the DN4 (douleur neu-
ropathique en 4 questions) [4,9]. Patients were catgorized as DN4 positive (at least three of 
seven neuropathic symptoms present) or negative (fewer than three neuropathic symptoms pre-
sent) [4,9]. The questionnaires were either filled in electronically by the patient after receipt of 
a link via e-mail or via a telephone interview.  
According to the NRS score for average pain six months after surgery, patients were allocated 
to the groups pain-free (NRS=0), mild pain (NRS=1-2), moderate pain (NRS=3-5) or severe 
pain (NRS ≥6). In line with previous studies and the Initiative on Methods, Measurement and 
Pain Assessment (IMMPACT) recommendations, CPSP was defined as persistent “clinically 
meaningful pain” with an NRS score ≥3 for average pain [9,12,27]. CPSP was considered as 
absent when average pain was <3. 
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Data analysis and statistics 
A download from the coded PAIN OUT database was performed in June 2017. Only data from 
hospitals contributing at least 50 complete datasets from patients having undergone major sur-
gery in the departments of general surgery, orthopedic surgery, gynecology and neurosurgery 
(four surgical groups) were included. The neurosurgical group consisted of patients undergoing 
surgery on the spinal canal and spinal fusions. The anonymized data set provided from PAIN 
OUT for this statistical analysis included some butno  all of the patients in the euCPSP study 
(enrollment 7/2011 to 12/2012), due to more rigorous inclusion criteria [9]. Based on our previ-
ous investigation showing a 5.6% incidence of neuropathic CPSP and inclusion of four surgical 
groups, we aimed at a sample size of at least 2,000 cases completing the BPI and DN4 ques-
tionnaires six months after surgery. We expected this would give us a representative cohort of 
patients (>100 patients with neuropathic CPSP) for reliable statistical analysis. An additional 
ethics approval was obtained for this analysis of registry data from the local ethics committee 
(KEK Bern: 2017-01157). 
The aim of our study was to investigate functional i terference six months after surgery with 
the main hypothesis that pain and DN4 have an influe ce on PITS. An ordinal regression model 
with the factors CPSP / no CPSP (NRS average pain ≥3 or <3) and DN4 negative/positive as 
well as their interactions on PITS was fitted. PITS was used as a dependent three-stage factor 
(no to mild functional interference (PITS <2), moderat  interference (PITS 2-5) or severe inter-
ference (PITS >5) [26]. Estimated odds ratios (OR) with 95% confidence intervals were report-
ed. Additionally, a multivariate linear regression model with the factors CPSP/no CPSP and 
DN4 negative/positive, including their interactions, was performed as a sensitivity analysis. Es-
timated regression coefficients with 95% confidence int rvals were calculated. Goodness-of-fit 
of the regression model was assessed by the coefficient of determination R2. 
ROC (receiver operating characteristic) analysis waused to discriminate between patients with 
severe interference (PITS >5) and patients with no to moderate interference (PITS ≤5) based on 
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average pain scores at six months. Accuracy was assessed by the area under the curve (AUC) 
with 95% confidence intervals (CI) and by predictive values at the chosen cut-off value of aver-
age pain. We additionally applied the ROC analysis for the cut-off PITS ≥2 versus PITS <2 to 
discriminate between patients who had at least moderate interference and patients who had no 
to mild interference. 
 
Finally, we were interested in possible risk factors associated with impaired function six months 
after surgery. A multivariate ordinal regression model was set up and fitted with the three PITS 
groups to estimate the risk of increased pain-related interference including a pre-specified set of 
possible predictors as independent variables. These predictors were variables referring to pa-
tient-reported outcome evaluated on the first postoperative day (pain intensity, % of time in se-
vere pain, side effects, a composite score of pain-related interference, satisfaction, and emotion-
al aspects such as feeling anxious or helpless). Covariates included were pre-existing chronic 
pain, pre-existing opioid therapy, and surgery-related variables (surgical group, duration of sur-
gery). As sex, age and BMI may also influence outcome, these patient characteristics were in-
troduced as confounders into the model. Odds ratios (OR) of the risk factors and corresponding 
95% CI are presented. 
Continuous data and composite scores were described by mean±SD (standard deviation), and 
NRS scores by medians with interquartile ranges. Categorical data were presented as absolute 
and relative frequencies. Differences in continuous tcomes were tested by two-sided inde-
pendent samples (t test or ANOVA) if the data were normally distributed; otherwise, the Mann-
Whitney U test or the Kruskal-Wallis test was applied. Differences in the frequency of categori-
cal outcomes were analyzed by the χ2 test. The significance level was set at p=0.05. To address 
the problem of multiple comparisons, Bonferroni correction was applied for the analysis of BPI 
scores/PITS in the subgroups of patients with different pain intensities and positive or negative 
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DN4. Statistical analyses were performed with IBM SPS  Statistics 23.0 (IBM Corp., Armonk, 
NY).  
 
RESULTS 
Study cohort and patient characteristics 
In the PAIN OUT database 2,872 patients were identifi d who had filled in the six-month ques-
tionnaire (Figure 1). After exclusion of cases with incomplete data, 2,322 patients with com-
pleted BPI could be analyzed. Six months after surgery, 20.1% of the patients noted mild pain, 
12.3% moderate pain and 3.0% severe pain (Figure 1). This resulted in 15.3% of the patients 
with CPSP, defined by an average pain score of NRS ≥3 at six months. Characteristics of pa-
tients with and without CPSP as well as their surgery-r lated and anesthesia-related data are 
displayed in Table 1. There was a significant difference in the incidence of CPSP between the 
four surgical groups (Table 1, p<0.001; Figure S1 in the supplemental digital content, available 
at http://links.lww.com/PAIN/A773). Particularly after neurosurgery and orthopedic surgery, 
the incidence was high. An analysis of individual surgeries revealed relatively low percentages 
of affected patients after laparoscopic cholecystectomy (6.5%), bariatric surgery (7.8%) and 
Cesarean delivery (8.1%), and increasing incidence after hernia repair (12.5%), breast surgery 
(14.7%), thoracotomy for lung resection (16.1%), total hip arthroplasty (20.8%), and total knee 
arthroplasty (30.9%).  
Comorbidities did not vary between patients with and without CPSP. Pre-existing chronic pain 
for at least three months before surgery was more frequent in patients later suffering from CPSP 
than in patients without CPSP (Table 1, p<0.001). Most patients indicated their pre-existing 
pain to be located at the site of surgery (56.2%), elsewhere (15.7%), or at the site of surgery and 
elsewhere (28.1%). The majority of patients undergoing orthopedic surgery and neurosurgery 
reported pre-existing chronic pain (70.4%). Opioids were more frequently taken before surgery 
in patients with CPSP compared to those without CPSP (0.001; Table 1). The proportion of pa-
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tients taking preoperative opioids was particularly high in orthopedic and neurosurgical patients 
(7.4% and 15.2%, respectively). 
 
Neuropathic symptoms six months after surgery 
The DN4 was filled in by 2,066 patients (Figure 1). Six months after surgery, neuropathic pain 
was reported by 39.8% of the patients with CPSP. Neuropathic pain was more frequent in pa-
tients suffering from severe CPSP (58.2%) than from moderate CPSP (38.7%; p=0.004 com-
pared to severe pain) or mild pain (25.0%; p<0.001 compared to moderate pain). Interestingly, 
some patients who indicated no pain at all reported three or more neuropathic symptoms (2.8%; 
p<0.001 compared to mild pain). Neuropathic pain qualities differed by type of surgery, with 
36.8% of the patients having a positive DN4 after thoracotomy, 33.3% after neurosurgical back 
surgery, 20.2% after knee arthroscopy, 18.3% after br ast surgery and 17.0% each after total 
hip arthroplasty, total knee arthroplasty and Cesarean delivery. In particular, some women after 
Cesarean delivery and breast surgery categorized in the group “no CPSP” indicated neuropathic 
symptoms, with a positive DN4 in 15.7% of the women after Cesarean delivery and 13.5% after 
breast surgery.  
Table S1 in the supplemental digital content gives further details of patient characteristics and 
results of patient-reported outcomes evaluated on the first postoperative day, for the groups 
with or without CPSP and negative or positive for DN4 (available at 
http://links.lww.com/PAIN/A773). 
 
Interaction of PITS with pain scores and DN4 sores 
The PITS differed in patients with no pain, mild, moderate and severe pain six months after 
surgery, with 0.2%, 2.4%, 21.4% and 61.4% reporting severe pain-related interference (Figure 
2A; p<0.001). Thus, high PITS were also present in some patients allocated to the no pain, mild 
and moderate pain groups according to their average p in score at six months. In contrast, 1.4% 
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of the patients with moderate CPSP and 1.8% of the patients with severe CPSP did not report 
any functional interference.  
In each of the subgroups with no pain, mild, moderate or severe pain, those subjects presenting 
with a positive DN4 were more impaired than those with a negative DN4 (Figure 2B). The or-
dinal regression analysis using PITS as a three-stage factor (no to mild functional, moderate or 
severe interference) revealed that in case of a positive DN4, there was a 29% increased risk for 
a higher PITS group (OR=1.29 (1.12-1.45); p<0.001), which was comparable in patients with 
CPSP (1.27 (1.10-1.51)) and with no CPSP (1.31 (1.01- 53)). In patients with CPSP, the risk 
for a higher PITS group was increased by 190% (OR=2.9 ( .7-3.2); p<0.001) compared to 
those without CPSP. An interaction between CPSP and DN4 was not detected (p=0.807). For 
sensitivity analysis, we performed an additional approach using multivariate linear regression 
analysis. In a patient with “average” pain scores at ix months (mean pain score of the whole 
cohort NRS=0.93), an increase of one point in the DN4 score resulted in a 0.26 higher PITS 
score on average (ßDN4=0.26 (0.21-0.30); p<0.001). Conversely, if average pain increased by 
one point in a patient with average neuropathic sympto s (mean DN4 score of the whole co-
hort 0.92), PITS scores were on average 0.70 higher (ßavg.pain=0.79 (0.66-0.74); p<0.001). There 
was a positive interaction between DN4 and pain scores regarding PITS; however, the com-
bined additional influence was rather small (ßDN4*avg.pain=0.02 (0.003-0.036); p=0.021). The co-
efficient of determination revealed a good fit in the model with R2=0.68, i.e. 68% of the varia-
tion of PITS was explained by average pain and DN4 score in the model. 
Comparing the domains of pain-related physical and ffective interference, patients with neuro-
pathic CPSP reported higher composite scores for afective and physical interference and com-
posite pain scores as well as higher scores for the sev n individual measures of interference 
compared to those with DN4-negative CPSP (Figure 3).  
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Prediction of PITS by pain scores 
ROC analysis showed good discrimination between patients with severe interference and pa-
tients with PITS ≤5 according to the average pain score at six months ( =2,322 with completed 
BPI; AUC (95% CI): 0.94 (0.91-0.97), p<0.001). Using the cut-off value defined for CPSP in 
this trial, the negative predictive value was 99.3% (1,952 of 1,966 patients). In contrast, the 
positive predictive value amounted to only 29.3%, as only 104 patients suffering from CPSP 
reported severe functional interference. By choosing a cut-off of PITS <2 versus PITS ≥2 to 
discriminate between patients with clinically relevant interference and those without, compara-
bly good prediction could be confirmed using averag pain (AUC (95% CI): 0.94 (0.92-0.96), 
p<0.001).  
 
Variables associated with pain-related interference 6 months after surgery 
Multivariate ordinal regression analysis revealed younger age, preexisting chronic pain before 
surgery, percentage of time suffering from severe pain in the first 24 hours after surgery, dura-
tion of surgery, as well as feeling anxious as variables significantly associated with PITS (Table 
2). Furthermore, we found an interaction between surgery and sex; therefore, males and females 
in the four surgery groups were analyzed separately. Males undergoing neurosurgery had a 
nearly 3.6 times increased risk of higher PITS compared to the reference group (males undergo-
ing general surgery), while the risk for females was 1.9 times higher. For males and females af-
ter orthopedic surgery, the OR amounted to 1.38 and 1.77, respectively (Table 2).  
  
Analgesics 6 months after surgery 
Six months after surgery, 17.4% of all patients repo ted the intake of analgesics, in most cases 
non-opioid analgesics. Use of opioid medication was more frequent in patients with higher 
PITS (Table 3). In the patient group with severe pain-related functional interference, more than 
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a quarter took WHO II or WHO III opioids, whereas percentages were lower in the groups with 
moderate, mild or no functional interference (p<0.001). 
 
DISCUSSION 
 
Pain-related functional interference in patients suffering from (neuropathic) CPSP was analyzed 
in a large patient cohort six months after surgery. CPSP and a positive DN4 were independently 
associated with patients’ increased pain-related functional interference six months after surgery. 
The risk increase due to CPSP did not depend on the DN4 status (i.e., was the same for patients 
with positive or negative DN4) and the risk increas due to DN4 was the same for patients with 
or without CPSP. Of the patients suffering from CPSP, 29% reported severe pain-related inter-
ference.  
We focused on PITS encompassing the physical and affective dimensions, as the impact of 
chronic pain states on activities of daily living seems to be more meaningful than pain intensity 
scores alone [18]. Additionally, the outcome functional interference might better capture the 
social consequences of a chronic pain state [13,18]. 
 
CPSP: Previous research     
The definition of CPSP in the new ICD-11 indicates a clear time interval (at least 3 months fol-
lowing surgery) for diagnosis of CPSP [31]. The time interval was a variable inconsistently 
used in previous publications, thus explaining some of the variance in reported incidence of 
CPSP [13,21,36]. Some working groups defined CPSP as any pain (NRS/VAS >0), resulting in 
high proportions of patients affected by CPSP [7,10,1 ,16]. Others used NRS ≥3 or NRS ≥4 as 
cut-offs [1,9,14,27,37]. If we apply a cut-off of 4 instead of 3 for classification of CPSP in our 
study, 200 (9.8%) instead of 338 patients would be allocated to the CPSP group.  
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In contrast, no cut-offs for pain intensity are given in the ICD-11 definition of CPSP. Instead, it 
is emphasized that pain should have a significant impact on quality of life [19,36], which might 
reflect the complexity of pain, with not only its sensory dimension but additional psycho-social 
consequences. Not considering function or even the multidimensionality of persistent pain may 
lead to erroneous conclusions regarding the pathophysiological mechanisms involved, and thus 
lead to an inadequate treatment approach [19,36]. In the present analysis, PITS significantly 
varied between the groups with no, mild, moderate and severe pain. However, existence of 
CPSP does not automatically imply moderate or severe functional impairment. This underlines 
previous results showing that pain intensity and physical functioning are only moderately relat-
ed [32]. 
 
Pain-related interference and (neuropathic) CPSP  
Few working groups investigated sensory dysfunction, frequently interpreted as an indicator of 
neuropathic pain, in patients without CPSP [17,23,38]. However, quantitative sensory testing 
and pressure algometry in patients after inguinal herniotomy did not demonstrate differences 
between patients with, versus without, pain [23]. Hypoesthesia and tactile allodynia in the inci-
sional area were detected in about half of the patients in both groups, showing low specificity of 
neuropathic symptoms for CPSP. Other authors described an association between self-reported 
sensory disturbances and CPSP, but no difference in QST measures in cohorts with and without 
CPSP [17]. The present results confirm sensory dysfunction in some patients with no pain; 
however, it has to be stated that the DN4 is not specifically validated in this patient group not 
reporting pain. The finding that DN4-positive CPSP resulted in higher PITS than DN4-negative 
CPSP underlines the fact that neuropathic pain is more disabling than pain without neuropathic 
symptoms [9,13,29]. Additionally, the negative impact of neuropathic symptoms on function 
was not restricted to patients with CPSP, but was also observed in patients with pain scores of 
NRS <3. 
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In some studies acute neuropathic pain after surgery and persistent chronic neuropathic pain 
were associated [13,22,25]. A positive DN4 during the immediate postoperative period seems 
to be a risk factor for neuropathic CPSP and adds to the list of other well-described variables 
associated with CPSP [2,22,25,29]. Thus, early detection and treatment of neuropathic pain 
within the first days after surgery might provide an opportunity to initiate early treatment in or-
der to avoid later interference with function.  
Prevalence estimates of neuropathic pain depend on the screening instrument used – either spe-
cific neuropathic questionnaires or more sophisticated neurophysiological methods [13]. No 
comprehensive physical examination is included in PAIN OUT. A misclassification of some 
subjects might be possible if only the DN4 is applied [13,30], although this instrument has been 
used successfully in previous trials [2,3,22,25]. Overall, the role of neuropathic pain question-
naires and their performance in the perioperative setting has to be clarified [13,30], and suitable 
instruments for assessing neuropathic symptoms as part of clinical routine should be defined. 
 
Variables associated with increased pain-related interference   
Regression analysis revealed roughly the same variables ssociated with high PITS as previous-
ly described for CPSP. Presence of pre-existing chronic pain before surgery is a well-
recognized risk factor for CPSP [7,9]. The present data confirm an association with high PITS 
as well. There is disagreement over whether pain after surgery is a new instance of pain or a 
continuation of pre-existing chronic pain [20]. In the Tromsø study, 74.1% of the individuals 
having preoperative pain at the surgical site responded that chronic postoperative pain was not a 
continuation of previous pain, as the type of pain had changed [16]. In particular, patients un-
dergoing joint replacement frequently report long-lasting preoperative chronic pain (e.g., osteo-
arthritis) at the surgical site [16].  
Severe acute postoperative pain after surgery has often been often been linked to CPSP; howev-
er, as pointed out before, the duration of severe acute pain during the first 24 hours after surgery 
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proved to be more meaningful than pain intensity [9]. Particularly interesting is the interaction 
between sex and type of surgery. High PITS in males fter neurosurgical back surgery are strik-
ing. We do not have any information on patients’ occupational (physical) burden or disability 
(mean age of neurosurgical patients is 57). This may differ between males and females. As the 
overall number of neurosurgical patients was relatively small, results have to be verified in a 
larger cohort with a more detailed evaluation of patient characteristics. 
 
Limitations and strengths 
These registry data are based on patient-reported outcomes assessed by validated question-
naires. Some psychological factors – such as pain catastrophizing, pain expectation as well as 
pain sensitivity – were not considered, although they ave previously been linked to high post-
operative pain intensity and the development of CPSP. In addition, only clinical data of the first 
postoperative day were considered to assess acute pain. The investigated cohort underwent var-
ious surgical procedures, and results may differ for different surgical subgroups.  
A large cohort of patients representing everyday clinical practice was analyzed, using the BPI. 
Its psychometric adequacy has been demonstrated in patients suffering from cancer and chronic 
non-cancer pain and it is recommended by IMMPACT [8]. Although the BPI was used to assess 
physical and emotional functioning after mastectomy in one study before [15], most previous 
trials focused on unidimensional pain assessment only, which does not fully reflect the complex 
interplay between biological, psychological and environmental factors [5]. In contrast, the BPI 
addresses one key aspect of recovery after surgery – the return to normal activities of daily liv-
ing [26] – thus meeting the respective criteria mentioned in the ICD-11 definition.  
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Conclusions 
An analysis of registry data revealed that CPSP and a positive DN4 were independently associ-
ated with patients’ increased pain-related functional i terference six months after surgery. Fu-
ture studies on CPSP should focus on pain-related functional interference instead of only pain 
scores. As a positive DN4 is an independent risk factor for increased PITS, also in patients with 
mild or no pain six months after surgery, we need btter and earlier identification of patients 
with neuropathic symptoms.  
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Figure Legends 
 
Figure 1 
Flow chart with number (%) of patients. CPSP, chronic postsurgical pain; BPI, Brief Pain 
Inventory. 
 
Figure 2 
Pain Interference Total Scores of the BPI (PITS) six months after surgery. (A) Patients 
with no, mild, moderate and severe average pain (ANOVA: p<0.001). The numbers beneath the 
x-axis represent the number of patients in each group. (B) Patients with no, mild, moderate and 
severe pain with either negative or positive DN4. Scatter dot plots with mean and 95% CI; 
dashed blue lines refer to the PITS of NRS=2 presenting the cut-off between mild and moderate 
pain related functional interference, and PITS of NRS=5 presenting the cut-off between moder-
ate and severe pain related functional interference. 
 
Figure 3 
Results of the BPI six months after surgery for patients without and with CPSP, either 
with negative or positive DN4. (A) BPI pain scores, (B) BPI physical interference, (C) BPI af-
fective interference. (D) Pain Interference Total Score (PITS) for the four groups, grey-tones re-
fer to patients no CPSP/DN4-, with no CPSP/DN4+, with CPSP/DN4- and with CPSP/DN4+ 
(left to right). Box (1st/3rd quartiles and median), whiskers (10-90% percentile), +: mean NRS 
score. * p<0.05; ** p<0.0001 refer to comparison of CPSP with negative versus positive DN4, 
corrected for multiple testing (15 tests).  
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Table 1 :  Patient characteristics, surgery-related and anesthesia-related data of patients with 
CPSP or without CPSP six months after surgery.  
 
 
 No CPSP CPSP  p a 
Females                              n 
(%) 
Males                                  n 
(%) 
Age                                         
years 
Weight                                     kg 
Height                                     
cm 
1289 (86.0) 
 678 (82.4) 
51.8 (51.1-52.5) 
81.9 (80.9-83.0) 
169.3 (168.9-169.7) 
210 (14.0) 
145 (17.6) 
51.7 (50.1-53.4) 
81.3 (79.1-83.5) 
169.7 (168.8-170.6) 
 
0.021 
 
0.887 
0.627 
0.360 
Patients’ history  
Patients with pre-existing 
chronic pain b                    
    Yes                                   n 
(%) 
    No                                     n 
(%) 
 
   
  704 (36.1) 
1247 (63.9) 
 
 
238 (67.2) 
116 (32.8) 
 
 
<0.001 
Pain scores c                        NRS  6.0 (4.0/8.0) 7.0 (5.0/8.0) <0.001 
Opioids before surgery d           n 
(%) 
65 (3.3) 36 (10.3) <0.001 
Substance abuse e               n 
(%) 
29 (1.4) 9 (4.2) 0.002 
Affective disorders e             n 
(%) 
144 (8.6) 32 (10.6) 0.252 
Surgical group     
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General surgery f                           n 
(%) 
Orthopedic surgery                       n 
(%) 
Gynecology                                         n 
(%) 
Neurosurgery                                     n 
(%) 
826 (90.4) 
493 (75.5) 
585 (89.0) 
 63 (64.3) 
88 (9.6) 
160 (24.5) 
 72 (11.0) 
 35 (35.7) 
 
 
<0.001 
 
Duration of surgery               
min 
144.6 (140.6-148.5) 150.1 (141.5-158.7) 0.382 
 
 
Data presented as n (%), mean (95% CI) or median NRS (1st/3rd quartile). Data refer to 2322 
questionnaires if not otherwise indicated. a: χ2 test, T-test or Mann-Whitney U test; b: refers to 
2305 patients; c: refers to patients reporting chronic pain before surgery, d: refers to 2302 
patients; e: refers to 1930 patients; f: includes thoracic surgery, CPSP for thoracic surgery 15.9%. 
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Table 2: Results of the multivariate ordinal regression analysis. Patients (n=1495) were 
allocated to PITS groups (no to mild functional interference, moderate interference, severe 
interference).  
 
  
Variables OR 95% CI P 
Pre-existing chronic pain: yes vs. no (reference) 3.61 2.56-5.08 <0.001 
Preoperative opioids: yes vs. no (reference) 1.47 0.83-2.58 0.178 
Duration of surgery (min) 1.002 1.000-1.004 0.020 
Time in severe pain D1 (%) 2.90 1.32-6.39 0.008 
Satisfaction with pain treatment  D1 (NRS) 0.95 0.88-1.03 0.181 
Pain relief D1 (%) 1.21 0.59-2.49 0.593 
Desire for more treatment D1: yes vs no (reference) 0.95 0.57-1.58 0.836 
Pain interferences composite score, D1  (NRS) 1.06 0.96-1.17 0.237 
Feel anxious D1 (NRS) 1.11 1.03-1.19 0.005 
Feel helpless  D1 (NRS) 0.96 0.89-1.03 0.228 
Adverse events D1 (number of episodes) 1.05 0.96-1.14 0.239 
Younger age (years) 1.01 1.001-1.02 0.033 
BMI (kg/m2)  1.01 0.98-1.03 0.566 
General surgery & male (reference) 
    General surgery & female 
    Gynecological surgery & female 
    Orthopedic surgery & male  
    Orthopedic surgery & female  
    Neurosurgery & female 
    Neurosurgery & male 
1 
0.484 
0.755 
1.383 
1.772 
1.889 
3.565 
 
0.276-0.850 
0.432-1.319 
0.829-2.308 
1.038-3.023 
0.861-4.144 
1.686-7.538 
 
0.012 
0.324 
0.214 
0.036 
0.113 
0.001 
  
D1; first postoperative day 
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Table 3: Number (%) of patients allocated to the groups with no (PITS=0), mild (PITS >0 and 
<2), moderate (PITS 2-5) and severe pain-related functional interference (PITS >5) taking 
analgesics according to WHO classification I-III, taking co-analgesics, having physiotherapy 
and / or other measures six months after surgery.  
 
 Functional interference None 
n=1423 
Mild 
 n=485 
Moderate 
n=291 
Severe 
n=117 
Analgesics a                   n 
(%) 
      WHO I 
      WHO II 
      WHO III 
      Co-analgesics b                   
Physiotherapy b                    
Others, e.g. acupuncture b                   
35 (2.5) 
31 (2.2) 
0 (0.0) 
4 (0.3) 
0 (0.0) 
4 (0.3) 
1 (0.07) 
105 (21.6) 
98 (20.2) 
3 (0.6) 
4 (0.8) 
1 (0.2) 
31 (6.4) 
10 (2.1) 
172 (59.1) 
129 (44.3) 
18 (6.2) 
22 (7.6) 
16 (5.5) 
37 (12.7) 
5 (1.7) 
90 (76.9) 
58 (49.6) 
6 (5.1) 
25 (21.4) 
7 (6.9) 
8 (6.8) 
8 (6.8) 
 
 
Of the 2322 patients with completed BPI, six did not provide information on analgesic thera-
py. Thus, data refer to 2316 patients. Multiple answers were possible.  a: refers to WHO an-
algesics and co-analgesics; b: alone or in combination.  
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPSP                     355 (15.3) 
  
  Moderate pain    285 (12.3) 
  Severe pain          70 (3.0) 
 
   Patients with general, orthopedic, gynecologic or neurosurgery                  2356 
No CPSP             1967 (84.7) 
 
  No pain     1498 (64.5) 
  Mild pain           469 (20.2) 
 
   Patients with complete BPI          2322 
Incomplete BPI                    34 
Incomplete DN4                256 
 
     Download PAIN OUT  
   Patients with questionnaires 6 months after surgery                                 2474 
Excluded: urology, ENT 
cardiovascular, missing data,          
incomplete data                 121 
DN4  
negative     
1583 (91.6) 
 
   Patients with complete DN4                                                                         2066 
CPSP                     338 (16.4) 
  
  Moderate pain      271 (13.1) 
  Severe pain            67 (3.2) 
 
No CPSP          1728 (83.6) 
 
   No pain          1292 (62.5) 
   Mild pain         436 (21.1) 
DN4 
positive 
145 (8.4) 
DN4  
negative     
194 (57.4) 
DN4 
positive 
144 (42.6) 
 
Pain:  
No       1256 
Mild       327  
 
 
Pain:  
No           36 
Mild      109 
 
Pain: Mode-
rate       166 
Severe   28 
 
Pain: Mode-
rate        105 
Severe    39 
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